These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 20014453)

  • 1. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
    Zlobec I; Lugli A
    World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
    Zlobec I; Lugli A
    Oncotarget; 2010 Nov; 1(7):651-61. PubMed ID: 21317460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
    Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
    Giger OT; Comtesse SC; Lugli A; Zlobec I; Kurrer MO
    Mod Pathol; 2012 Jul; 25(7):1048-53. PubMed ID: 22481282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.
    Lugli A; Karamitopoulou E; Panayiotides I; Karakitsos P; Rallis G; Peros G; Iezzi G; Spagnoli G; Bihl M; Terracciano L; Zlobec I
    Br J Cancer; 2009 Oct; 101(8):1382-92. PubMed ID: 19755986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
    Karamitopoulou E; Zlobec I; Kölzer V; Kondi-Pafiti A; Patsouris ES; Gennatas K; Lugli A
    Mod Pathol; 2013 Feb; 26(2):295-301. PubMed ID: 23018875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and diagnostic significance of tumor budding associated with β-catenin expression in submucosal invasive colorectal carcinoma.
    Umemura K; Takagi S; Shimada T; Masuda T; Shiga H; Takahashi S; Takahashi S; Kinouchi Y; Shibuya D; Shimosegawa T
    Tohoku J Exp Med; 2013 Jan; 229(1):53-9. PubMed ID: 23238650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined score.
    Dawson H; Christe L; Eichmann M; Reinhard S; Zlobec I; Blank A; Lugli A
    Histopathology; 2020 Mar; 76(4):572-580. PubMed ID: 31560788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.
    Fujiyoshi K; Väyrynen JP; Borowsky J; Papke DJ; Arima K; Haruki K; Kishikawa J; Akimoto N; Ugai T; Lau MC; Gu S; Shi S; Zhao M; Da Silva AFL; Twombly TS; Nan H; Meyerhardt JA; Song M; Zhang X; Wu K; Chan AT; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    EBioMedicine; 2020 Jul; 57():102860. PubMed ID: 32652320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous analysis of tumor-infiltrating immune cells density, tumor budding status, and presence of lymphoid follicles in CRC tissue.
    Markowski AR; Markowska AJ; Ustymowicz W; Pryczynicz A; Guzińska-Ustymowicz K
    Sci Rep; 2022 Dec; 12(1):21732. PubMed ID: 36526699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
    Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
    Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
    Zlobec I; Minoo P; Terracciano L; Baker K; Lugli A
    Histopathology; 2011 Sep; 59(3):482-95. PubMed ID: 22034888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding: a promising parameter in colorectal cancer.
    Lugli A; Karamitopoulou E; Zlobec I
    Br J Cancer; 2012 May; 106(11):1713-7. PubMed ID: 22531633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis?
    Jiang B; Mason J; Jewett A; Qian J; Ding Y; Cho WC; Zhang X; Man YG
    Int J Biol Sci; 2013; 9(1):119-33. PubMed ID: 23355797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?
    Jiang B; Mason J; Jewett A; Liu ML; Chen W; Qian J; Ding Y; Ding S; Ni M; Zhang X; Man YG
    Int J Med Sci; 2013; 10(5):475-97. PubMed ID: 23532368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.
    Konishi Y; Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Kohsaka S; Einama T; Liu C; Yoshida T; Nagatsu A; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
    Med Oncol; 2018 Jun; 35(7):104. PubMed ID: 29892782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Budding in Colorectal Carcinoma Showing a Paradoxical Mitotic Index (Via PHH3) With Possible Association to the Tumor Stromal Microenvironment.
    Hacking S; Sajjan S; Angert M; Ebare K; Jin C; Chavarria H; Kataria N; Zhang L; Cho M; Thomas R; Lee L; Nasim M
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):627-634. PubMed ID: 31567276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma.
    Aboelnasr LS; El-Rebey HS; Mohamed A; Abdou AG
    Turk Patoloji Derg; 2023; 39(1):83-93. PubMed ID: 35642343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
    Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
    BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.